Xiaomi-backed Nuclei Sys tests public markets with RISC-V expansion still costly

Nuclei Systems’ IPO initiation signals a shift in the RISC-V ecosystem from technological validation to capital-driven growth. Despite sustained R&D expenditures exceeding revenue, its over 80% gross margin underscores a strategic positioning in differentiated architecture. This move accelerates upstream EDA toolchain and downstream OS adaptation, especially in AIoT and edge computing. From a compliance standpoint, ongoing U.S.-China tech decoupling forces companies to reassess supply chain strategies, particularly in IP licensing and manufacturing. Competitors may respond with intensified resource consolidation to counter capital inflows. Over the next 12-24 months, RISC-V will face dual pressures of standardization and market expansion. Nuclei’s listing could mark a turning point for industry capitalization, though achieving profitability remains uncertain.